Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Wee_S' OR with Authors including 'Wee_S' OR with Abstract including 'Wee_S' OR with Keywords including 'Wee_S'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Burroughs W Letter From A Master Addict To Dangerous Drugs British Journal of A... 1956
Pierre R Effets sur l'EEG du lapin d'une intoxication chronique ou aiguë par la... Compt. rend. Soc. Bi... 1957
Lewis DJ, Sloane RB Therapy with lysergic acid diethylamide J. Clin. & Exper. Ps... 1958
Pierre R, Cahn J, Herold ... Actions de la 21 hydroxypregnanedione et du méthyl-androstanolone sur ... Thérapie 1958
Feld M, Goodman JR, Guido... Clinical and laboratory observations on LSD-25 J. Nerv. & Ment. Dis... 1958
Cahn J, Herold M, Dubrasq... Contribution à un concept biochimique des psychoses expérimentales. I... Compt. rend. Soc. de... 1958
Loeb C, Giberti F Lysergic acid diethylamide effects modified by hydroxyzine hydrochlori... Confinia neurol. 1959
Cahn J, Herold M Modifications du metabolisme cerebral chez le lapin in-vivo sous l'act... IInd International C... 1959
Baldwin M, Lewis SA, Bach... The effects of lysergic acid after cerebral ablation. Neurology (Minneapol... 1959
Turner WJ, Almudevar M, M... Chemotherapeutic trials in psychosis: III Addendum 2-brom-d-lysergic ... Amer.J.Psychiat. 1959
Smith CM Some Reflections on the Possible Therapeutic Effects of the Hallucinog... Quart.J.Stud.Alcohol... 1959
Chandler AL, Hartman MA Lysergic acid diethylamide (LSD-25) as a facilitating agent in psychot... A.M.A.Arch.Gen.Psych... 1960
Hoffer A, Callbeck MJ Drug-induced schizophrenia J.ment.Sci. 1960
Cohen S Lysergic acid diethylamide: side effects and complications J. Nerv. ment. Dis. 1960
Jarvik ME, Chorover S Impairment by lysergic acid diethylamide of accurracy in performance o... Psychopharmacologia 1960
Fox SS LSD alteration of optic potentials (cat lateral geniculate); block by ... Fed.Proc. 1960
van Ree F Prediction of syndromes under LSD-25 Advanc. Psychosom. M... 1960
Sankar S, Kopelman A, Sch... Effect of lysergic acid diethylamide on larval growth Nature 1960
Jovanovic D, Kandic B, Kr... Neka nasa iskustva u lecenju dusevnih bolesnika dietilamidom lizergicn... Vojno-sanit.Pregl. 1960
Ling TM, Buckman J The use of lysergic acid in individual psychotherapy Proc. roy. Soc. Med. 1960
Fontana AE El uso clínico de las drogas alusinógenas Acta neuropsiquiát. ... 1961
Hollister LE Clinical, biochemical and psychologic effects of Psilocybin Arch. internat. Phar... 1961
Ketchum JS, Aghajanian GK... THE HUMAN ASSESSMENT OF EA 1729 [LSD] AND EA 3528 BY THE INHALATION RO... CHEMICAL RESEARCH AN... 1964
Harman WW, McKim RH, Moga... Psychedelic agents in creative problem-solving: A pilot study Psychological Report... 1966
McGlothlin W, Cohen S, Mc... Long lasting effects of LSD on normals Arch Gen Psychiat 1967
Denson R Dissociative delirium after treatment with lysergide Canadian Medical Ass... 1967
McGlothlin W, Cohen S, Mc... Long lasting effects of LSD on normals Arch Gen Psychiat 1967
McGlothlin WH, Cohen S, M... Long-lasting effects of LSD on normals Drug Abuse, Social a... 1969
Pahnke WN, Kurland AA, Go... LSD-assisted psychotherapy with terminal cancer patients Psychedelic Drugs 1969
Pahnke WN, Kurland AA, Go... LSD-assisted psychotherapy with terminal cancer patients Curr Psychiatr Ther 1969
Schatz H, Mendelblatt F Solar retinopathy from sun-gazing under the influence of LSD Br J Ophthalmol 1973
Quadri SK, Clark JL, Meit... Effects of LSD, Pargyline and Haloperidol on Mammary Tumor Growth in R... Proc.Soc.Exp.Biol.Me... 1973
Wray SR., Cowan A Correlation Between Animal and Clinical Findings with a Psychotomimeti... Neuropharmacology 1973
Fuller RW, Snoddy HD Long-term effects of 4-chloroamphetamine on brain 5-hydroxyindole meta... Neuropharmacology 1974
Goetz P, Sram RJ, Zudová ... The Mutagenic Effect Of Lysergic Acid Diethylamide: I. Cytogenetic Ana... Mutation Res 1974
von Hungen K, Roberts S, ... LSD as an agonist and antagonist at central dopamine receptors. Nature 1974
Quadri SK Effects Of Central Acting Drugs And Ergot Derivatives On Prolactin And... Assertation Abst. In... 1974
Fuller RW, Perry KW Long-lasting depletion of brain serotonin by 4-chloroamphetamine in gu... Brain Res 1974
Wessely P, Mamoli B, Pres... EEG-Untersuchungen im Längsschnitt bei der Entwöhnung von jugendlichen... Psychiatria clin. 1975
Tenbrinck MS New Chromosomal And Malformation Syndromes Birth Defects. Orig.... 1975
Davis M, Sheard MH p-Chloroamphetamine PCA: acute and chronic effects on habituation and ... Eur J Pharmacol 1976
Siegel RK, Brewster JM, J... The Effects of Hallucinogens On Blind Monkeys Intern.Pharmacopsych... 1976
Cherkin A, Exkardt MJ Effects of dimethylaminoethanol upon life-span and behavior of aged Ja... J Gerontol 1977
Halaris AE, Freedman DX Vesicular And Juxtavesicular Serotonin: Effects Of Lysergic Acid Dieth... J Pharmacol Exp Ther... 1977
Richards WA., Rhead JC, D... The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer... Journal of Psychedel... 1977
Fuller RW, Meyers DB, Gib... Depletion of brain serotonin by chronic administration of p-chloramphe... Toxicol Appl Pharmac... 1979
Seeman P, Westman K, Cosc... Serotonin Receptors in Hippocampus and Frontal Cortex Europ.J.Pharmacol. 1980
Takeuchi Y, Ono Y, Hisana... A comparative study on the neurotoxicity of n-pentane, n-hexane, and n... Br J Ind Med 1980
Lake CR, Stirba AL, Kinne... Mania Associated with LSD Ingestion Am J Psychiatry 1981
Smith LAC, Meyerson BJ Influence of Long-term Zimeldine Treatment on LSD-induced Behavioural ... Actapharmacol et tox... 1984
Commins DL, Vosmer G, Vir... Biochemical and histological evidence that methylenedioxymethylampheta... J Pharmacol Exp Ther 1986
Battaglia G, Yeh SY, O'He... 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine de... J Pharmacol Exp Ther 1987
Frith CH, Chang LW, Latti... Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the ra... Fundam Appl Toxicol 1987
Peroutka SJ, Pascoe N, Fa... Monoamine metabolites in the cerebralspinal fluid of recreational user... Research Comm in Sub... 1987
Stone DM, Johnson M, Hans... A comparison of the neurotoxic potential of methylenedioxyamphetamine ... Eur J Pharmacol 1987
Stone DM, Merchant KM, Ha... Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... Neuropharmacology 1987
Nencini P, Woolverton WL,... Enhancement of morphine-induced analgesia after repeated injections of... Brain Res 1988
O'Hearn E, Battaglia G, D... Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... J Neurosci 1988
Ricaurte GA, DeLanney LE,... 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergi... Brain Res 1988
Ricaurte GA, Forno LS, Wi... (+/-)3,4-Methylenedioxymethamphetamine selectively damages central ser... JAMA 1988
Slikker W Jr, Ali SF, Sca... Neurochemical and neurohistological alterations in the rat and monkey ... Toxicol Appl Pharmac... 1988
Bhave SV, Telang SD, Durd... Effects of nutritional stress on brain tyramine concentration and dopa... Neurochem Res 1988
Greenblatt DJ Urine Drug Testing: What Does it Test? New England Law Revi... 1989
Insel TR, Battaglia G, Jo... 3,4-Methylenedioxymethamphetamine ('ecstasy') selectively destroys bra... J Pharmacol Exp Ther 1989
Johnson MP, Nichols DE Neurotoxic effects of the alpha-ethyl homologue of MDMA following suba... Pharmacol Biochem Be... 1989
Kleven MS, Woolverton WL,... Evidence that both intragastric and subcutaneous administration of met... Brain Res 1989
Li AA, Marek GJ, Vosmer G... Long-term central 5-HT depletions resulting from repeated administrati... Pharmacol Biochem Be... 1989
Bilsky EJ, Hui YZ, Hubbel... Methylenedioxymethamphetamine's capacity to establish place preference... Pharmacol Biochem Be... 1990
Poland RE Diminished corticotropin and enhanced prolactin responses to 8-hydroxy... Neuropharmacology 1990
Ricaurte GA, Finnegan KT,... Aminergic metabolites in cerebrospinal fluid of humans previously expo... Ann N Y Acad Sci 1990
Ruze P Kava-induced dermopathy: a niacin deficiency? Lancet 1990
Paris JM, Cunningham KA Lack of Neurotoxicity after Intra-Raphe Micro-Injections of MDMA ('Ecs... NIDA Res Monogr 1991
Warnecke G [Psychosomatic dysfunctions in the female climactericClinical effectiv... Fortschr Med 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Kinzler E, Kroemer J, Leh... [Effect of a special kava extract in patients with anxiety-, tension-,... Arzneimittelforschun... 1991
Battaglia G, Sharkey J, K... Neuroanatomic specificity and time course of alterations in rat brain ... Synapse 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Duffield PH, Jamieson D Development of tolerance to kava in mice Clin Exp Pharmacol P... 1991
Lehmann J, DeSouza EB, Cu... Regional distribution to recovery of 5-HT levels after administration ... Ann N Y Acad Sci 1992
McCann UD, Ricaurte GA MDMA ('ecstasy') and panic disorder: induction by a single dose Biol Psychiatry 1992
Paris JM, Cunningham KA Lack of serotonin neurotoxicity after intraraphe microinjection of (+)... Brain Res Bull 1992
Ricaurte GA, Martello AL,... Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on ce... J Pharmacol Exp Ther 1992
McCann UD, Ricaurte GA Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetam... J Clin Psychopharmac... 1993
Ricaurte GA, Markowska AL... 3,4-Methylenedioxymethamphetamine, serotonin and memory [published err... J Pharmacol Exp Ther 1993
Scanzello CR, Hatzidimitr... Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine ... J Pharmacol Exp Ther 1993
Merlin MD, Allen JW Species identification and chemical analysis of psychoactive fungi in ... J Ethnopharmacol 1993
Marsh JCW, Abboudi ZH, Gi... Aplastic anaemia following exposure to 3,4-methylenedioxymethamphetami... Br J Haematol 1994
McCann UD, Ridenour A, Sh... Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (... Neuropsychopharmacol... 1994
O'Callaghan JP, Miller DB Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mou... J Pharmacol Exp Ther 1994
Series HG, Cowen PJ, Shar... p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) a... Psychopharmacology (... 1994
Wotherspoon G, Savery D, ... Repeated administration of MDMA down-regulates preprocholecystokinin m... Brain Res Mol Brain ... 1994
Yau JL, Kelly PA, Sharkey... Chronic 3,4-methylenedioxymethamphetamine administration decreases glu... Neuroscience 1994
Johnson EJ, Emche SD Variation of Alkaloid Content in Erythroxylum coca Leaves from Leaf Bu... Annals of Botany 1994
Cadet JL, Ladenheim B, Hi... Superoxide radicals mediate the biochemical effects of methylenedioxym... Synapse 1995
Squier MV, Jalloh S, Hilt... Death after ecstasy ingestion: neuropathological findings J Neurol Neurosurg P... 1995
Ellis AJ, Wendon JA, Port... Acute liver damage and ecstasy ingestion Gut 1996
Chenard-Neu MP, Boudjema ... Auxiliary liver transplantation: regeneration of the native liver and ... Hepatology 1996
Malberg JE, Sabol KE, Sei... Co-administration of MDMA with drugs that protect against MDMA neuroto... J Pharmacol Exp Ther 1996
Gartside SE, McQuade R, S... Effects of repeated administration of 3,4-methylenedioxymethamphetamin... J Pharmacol Exp Ther 1996
Seiden LS, Sabol KE Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possi... NIDA Res Monogr 1996

Page 1 of 3   /   223 Entries Returned
Pages:     
 1 
2 3 next